FEZZA, FILOMENA

FEZZA, FILOMENA  

Dipartimento di Medicina Sperimentale  

Mostra records
Risultati 1 - 20 di 71 (tempo di esecuzione: 0.029 secondi).
Data di pubblicazione Titolo Autore(i) Tipo File
1-gen-2008 5-Lipoxygenase and anandamide hydrolase (FAAH) mediate the antitumor activity of cannabidiol, a non-psychoactive cannabinoid Massi, P; Valenti, M; Vaccani, A; Gasperi, V; Perletti, G; Marras, E; Fezza, F; Maccarrone, M; Parolaro, D Articolo su rivista
1-gen-2010 A new group of oxime carbamates as reversible inhibitors of fatty acid amide hydrolase Gattinoni, S; Simone, C; Dallavalle, S; Fezza, F; Nannei, R; Battista, N; Minetti, P; Quattrociocchi, G; Caprioli, A; Borsini, F; Cabri, W; Penco, S; Merlini, L; Maccarrone, M Articolo su rivista
1-gen-2013 Activation of type-2 cannabinoid receptor inhibits neuroprotective and antiinflammatory actions of glucocorticoid receptor α: when one is better than two. Bisicchia, E; Chiurchiù, V; Viscomi, M; Latini, L; Fezza, F; Battistini, L; Maccarrone, M; Molinari, M Articolo su rivista
1-gen-2017 Activity-based protein profiling reveals off-target proteins of the FAAH inhibitor BIA 10-2474 Van Esbroeck, Acm; Janssen, Apa; Cognetta, Ab; Ogasawara, D; Shpak, G; Van Der Kroeg, M; Kantae, V; Baggelaar, Mp; De Vrij, Fms; Deng, H; Allara, M; Fezza, F; Lin, Z; Van Der Wel, T; Soethoudt, M; Mock, Ed; Den Dulk, H; Baak, Il; Florea, Bi; Hendriks, G; De Petrocellis, L; Overkleeft, Hs; Hankemeier, T; De Zeeuw, Ci; Di Marzo, V; Maccarrone, M; Cravatt, Bf; Kushner, Sa; Van Der Stelt, M Articolo su rivista
1-gen-2020 Advances in the discovery of fatty acid amide hydrolase inhibitors: what does the future hold? Fazio, D; Criscuolo, E; Piccoli, A; Barboni, B; Fezza, F; Maccarrone, M Articolo su rivista
1-gen-2008 Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum Maccarrone, M; Rossi, S; Bari, M; De Chiara, V; Fezza, F; Musella, A; Gasperi, V; Prosperetti, C; Bernardi, G; Finazzi Agro', A; Cravatt, B; Centonze, D Articolo su rivista
1-gen-2016 Assay of NAPE-PLD Activity Fezza, F; Mastrangelo, N; Maccarrone, M Contributo in libro
1-gen-2020 Bisphenol a deranges the endocannabinoid system of primary sertoli cells with an impact on inhibin b production Rossi, G; Dufrusine, B; Lizzi, Ar; Luzi, C; Piccoli, A; Fezza, F; Iorio, R; D'Andrea, G; Dainese, E; Cecconi, S; Maccarrone, M Articolo su rivista
1-gen-2017 Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity Soethoudt, M; Grether, U; Fingerle, J; Grim, Tw; Fezza, F; De Petrocellis, L; Ullmer, C; Rothenhausler, B; Perret, C; Van Gils, N; Finlay, D; Macdonald, C; Chicca, A; Gens, Md; Stuart, J; De Vries, H; Mastrangelo, N; Xia, L; Alachouzos, G; Baggelaar, Mp; Martella, A; Mock, Ed; Deng, H; Heitman, Lh; Connor, M; Di Marzo, V; Gertsch, J; Lichtman, Ah; Maccarrone, M; Pacher, P; Glass, M; Van Der Stelt, M Articolo su rivista
1-gen-2004 Changes in endocannabinoid contents in reward-related brain regions of alcohol-exposed rats, and their possible relevance to alcohol relapse. González, S; Valenti, M; de Miguel, R; Fezza, F; Fernández Ruiz, J; Di Marzo, V; Ramos, Ja Articolo su rivista
1-gen-2008 Characterization of biotin-anandamide, a novel tool for the visualization of anandamide accumulation Fezza, F; Oddi, S; Di Tommaso, M; De Simone, C; Rapino, C; Pasquariello, N; Dainese, E; FINAZZI AGRO', A; Maccarrone, M Articolo su rivista
18-apr-2020 Characterization of Endocannabinoid System and Interleukin Profiles in Ovine AEC: Cannabinoid Receptors Type-1 and Type-2 as Key Effectors of Pro-Inflammatory Response Greco, L; Russo, V; Rapino, C; Germanio, Cd; Fezza, F; Bernabò, N; Berardinelli, P; Peserico, A; Fazio, D; Maccarrone, M; Mattioli, M; Barboni, B Articolo su rivista
1-gen-2005 Characterization of the endocannabinoid system in boar spermatozoa and implications for sperm capacitation and acrosome reaction Maccarrone, M; Barboni, B; Paradisi, A; Bernabo, N; Gasperi, V; Pistilli, Mg; Fezza, F; Lucidi, P; Mattioli, M Articolo su rivista
1-gen-2022 Chemical proteomics reveals off-targets of the anandamide reuptake inhibitor WOBE437 Gagestein, B; Stevens, Af; Fazio, D; Florea, Bi; Van Der Wel, T; Bakker, At; Fezza, F; Dulk, Hd; Overkleeft, Hs; Maccarrone, M; Van Der Stelt, M Articolo su rivista
2-dic-2023 Computational and Experimental Drug Repurposing of FDA-Approved Compounds Targeting the Cannabinoid Receptor CB1 Criscuolo, E; De Sciscio, Ml; De Cristofaro, A; Nicoara, C; Maccarrone, M; Fezza, F Articolo su rivista
1-gen-2005 Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis. Cabranes, A; Venderova, K; de Lago, E; Fezza, F; Sánchez, A; Mestre, L; Valenti, M; García Merino, A; Ramos, J; Di Marzo, V; Fernández Ruiz, J Articolo su rivista
1-gen-2007 Design and synthesis of biotinylated probes for n-acyl-ethanolamines Maccarrone, M; Oddi, S; Fezza, F; FINAZZI AGRO', A Brevetti
1-gen-2009 Design and synthesis of biotinylated probes for n-acyl-ethanolamines Maccarrone, M; Oddi, S; Fezza, F; FINAZZI AGRO', A Brevetti
1-gen-2014 Detailed characterization of the endocannabinoid system in human macrophages and foam cells, and anti-inflammatory role of type-2 cannabinoid receptor. Chiurchiù, V; Lanuti, M; Catanzaro, G; Fezza, F; Rapino, C; Maccarrone, M Articolo su rivista
1-gen-2019 Development of novel multipotent compounds modulating endocannabinoid and dopaminergic systems Grillo, A; Chemi, G; Brogi, S; Brindisi, M; Relitti, N; Fezza, F; Fazio, D; Castelletti, L; Perdona, E; Wong, A; Lamponi, S; Pecorelli, A; Benedusi, M; Fantacci, M; Valoti, M; Valacchi, G; Micheli, F; Novellino, E; Campiani, G; Butini, S; Maccarrone, M; Gemma, S Articolo su rivista